The decision gives certain patients whose cancer has resisted BCG therapy another treatment option aimed at preserving the ...

A large survey study finds that most bladder cancer patients who undergo cystectomy with urinary diversion continue to face ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...

Radical cystectomy, involving complete removal of the urinary bladder, is the principal curative intervention for muscle-invasive bladder cancer and selected high-risk non-muscle-invasive disease.

For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained. For patients with bladder cancer undergoing radical cystectomy (the surgical ...